Alteration in the gene copy number of EGFR has been related to poor survival in cutaneous melanoma [47], and HER-2 overexpression has been described in thick cutaneous melanomas (thickness ≥ 10 mm), even if without proven prognostic significance [35]. This evidence concerns the gene ERBB2 and cutaneous melanoma.